Macy Chan
Macy assumed the office of Medical Director at Moderna Hong Kong in March 2023.
Passionate in her pursuit of advancing public health, she aims to improve health outcomes for patients across Hong Kong and the wider APAC region.
Macy works with immunization technical advisors, medical societies, healthcare authorities and regulators, and key experts in the field to develop a better understanding of unmet medical needs, fostering collaboration to make a positive impact on healthcare.
She is committed to growing Moderna’s presence in Asia, helping the company become a leader in both prevention and treatment in the region.
Prior to Moderna, Macy worked in the pharmaceutical industry for 12 years as a Registered Public Health Nutritionist (RPHNutr) at primary care trusts and NGOs across the United Kingdom. Macy is a graduate of the University of Toronto and Queen Margaret University of Edinburgh.
Commentary
The strategic decarbonisation model for Hong Kong real estate
The survival playbook for the CEO amidst geopolitical conflicts
The succession shift: Redesigning wealth structures for the next generation
2026 biotech playbook: Hong Kong at the centre of China’s globalisation